Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Clascoterone and minocycline are effective acne treatments with quick results and fewer side effects.

Finasteride's solubility improves with native y-CDs, enhancing hair loss treatment and reducing side effects.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

New therapies are being developed that target integrin pathways to treat various diseases.

Zinc sulfide cellulose scaffolds can reduce scarring and promote hair growth.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Targeting ornithine decarboxylase can help prevent skin cancer.

Pexidartinib often causes liver issues and fatigue, especially in women.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.